References
- Zhang Z, Xu L, Zhang Z, et al. The need for contraception in patients taking prescription drugs: a review of FDA warning labels, duration of effects, and mechanisms of action. Expert Opin Drug Saf. 2018 Nov 3;12:1–13.
- Amundsen S, Nordeng H, Nezvalová-Henriksen K, et al. Pharmacological treatment of migraine during pregnancy and breastfeeding. Nat Rev Neurol. 2015;11:209–219.
- Marchenko A, Etwel F, Olutunfese O, et al. Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis. Headache. 2015;55:490–501.
- Bromley RL, Weston J, Marson AG. Maternal use of antiepileptic agents during pregnancy and major congenital malformations in children. JAMA. 2017;318:1700–1701.
- Kaplan YC. Lamotrigine and pregnancy: the discrepancies regarding the oral clefts and dose-dependent risk of malformations. BMJ. 2016;353:i1965.
- Malek A, Sager R, Eckardt KU, et al. Lack of transport of erythropoietin across the human placenta as studied by an in vitro perfusion system. Pflugers Arch. 1994;427(1–2):157–161.
- Widness JA, Schmidt RL, Sawyer ST. Erythropoietin transplacental passage–review of animal studies. J Perinat Med. 1995;23:61–70.
- Szurkowski M, Wiecek A, Kokot F, et al. Safety and efficiency of recombinant human erythropoietin treatment in anemic pregnant women with a kidney transplant. Nephron. 1994;67:242–243.
- Lydaki E, Nikoloudi I, Kaminopetros P, et al. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku. Transfusion. 2005;45:1791–1795.
- Brent RL. Bendectin: review of the medical literature of a comprehensively studied human nonteratogen and the most prevalent tortogen-litigen. Reprod Toxicol. 1995;9:337–349.